Print Friendly, PDF & Email

Radiology Trends at ECR 2013

During

During ECR 2013, GE Healthcare will be showcasing its latest developments in medical imaging providing more quality and affordable care

GE

GE Healthcare advanced and enhanced patient-friendly technology with comfortable environments for exams available to view at ECR 2013

GE Healthcare’s presence at ECR 2013 promises to be one of the highlights of the meeting as its products continue to contribute to healthier lifestyles for patients and individuals. This year, one of the aims is to underline the impact radiology imaging solutions have had on patient comfort through the innovative use of user-friendly functionality, enhancing workflow efficiencies, and caring designs.

In the rapidly changing healthcare environment, GE Healthcare has been a leader in setting the medical technologies agenda particularly in the radiology sector. Industry trends that were highlighted by GE Healthcare at RSNA last year now form the foundations in building a new path in how radiology works today and evolves in the future.

‘Patients First’ Theme

Patient welfare remains an ongoing theme at ECR 2013 with GE Healthcare hosting a series of forum sessions discussing the impact the latest imaging techniques have had on enhancing diagnostics, and streamlining workflow.

The SensorySuite for mammography continues the theme of providing a positive patient experience. Intended to divert a woman’s attention away from the discomfort, anxiety, and intimidation associated with mammography screenings, the SensorySuite helps improve patients experience by providing a personalized environment that appeals to the senses during a mammography examination.

Managing risk is a fundamental factor in successful patient care. Nowhere is this more clearly shown than in the tracking, reporting, and monitoring of radiation doses administered during imaging scans like CT that use x-ray radiation. GE Healthcare’s DoseWatch not only monitors the doses delivered during these procedures but also helps to meet regulatory and compliance requirements thanks to its dose tracking system and data display. It’s this functionality that is of great value in helping radiologists and technologists identify sub-optimal scanning protocols, improve parameter settings, and optimize patient radiation dose.

A Greater Presence in Ultrasound Imaging

With the growing use of ultrasound, healthcare providers are challenged to image patients of various ages and sizes, and encompass a wide range of clinical areas including abdominal, vascular, cardiac, musculoskeletal, OB/GYN, and small parts imaging. In response to this trend, GE Healthcare has updated its portfolio of ultrasound products. One of the latest innovations is the LOGIQ* E9 with XDclear—a versatile general imaging system that is well suited for a variety of general imaging needs. The LOGIQ E9 with XDclear can assist in the delivery of excellent image quality on a broad spectrum of patient body types as well as visualize blood flow without the limitations of Doppler. In addition it can also integrate real-time ultrasound with previously acquired CT, MR, PET, or ultrasound images.

The LOGIQ stable of products also includes the LOGIQ* S7. This mobile, shared-service ultrasound system is also designed to provide enhanced diagnostic confidence across applications. This is achieved through the use of a user-sensitive design that helps increase exam speed, as well as comfort and productivity. Intuitive tools that enable high utilization across multiple applications are included at an affordable price that helps meet expectations.

In the GE booth, the company will also showcase for the first time at ECR, the somo-v automated breast ultrasound system (ABUS) – a powerful tool that can help physicians find mammographically occult cancers in dense breast tissue. Our multi-reader, multi-case ROC study demonstrated that with the addition of ABUS to the screening mammography, radiologists found 35.7 percent more cancers in women who had normal or negative mammogram, >50% parenchymal breast density and no prior breast interventions.

* – Trademark of General Electric Company